Adjunctive brexpiprazole for the treatment of major depressive disorder.
about
The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder.Pharmacotherapy of major depression in late life: what is the role of new agents?Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine.
P2860
Adjunctive brexpiprazole for the treatment of major depressive disorder.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Adjunctive brexpiprazole for the treatment of major depressive disorder.
@en
Adjunctive brexpiprazole for the treatment of major depressive disorder.
@nl
type
label
Adjunctive brexpiprazole for the treatment of major depressive disorder.
@en
Adjunctive brexpiprazole for the treatment of major depressive disorder.
@nl
prefLabel
Adjunctive brexpiprazole for the treatment of major depressive disorder.
@en
Adjunctive brexpiprazole for the treatment of major depressive disorder.
@nl
P2860
P1476
Adjunctive brexpiprazole for the treatment of major depressive disorder.
@en
P2093
John L Beyer
Richard H Weisler
P2860
P304
P356
10.1080/14656566.2016.1254188
P407
P577
2016-10-27T00:00:00Z